InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Siegel Jolie, Directeur Juridique. Officer active across 1 company, notably C4 Therapeutics, Inc.. Aggregated, 11 disclosures have been published. Activity tracked since 29 July 2021. The latest transaction was disclosed on 13 February 2025 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Siegel Jolie
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations11 total
2,135 shares@ US$3.202.8% of flowCommon StockSEC:0001662579-25-000020:0
3,750 sharesCommon StockSEC:0001662579-24-000101:0
2,250 sharesCommon StockSEC:0001662579-24-000079:0
1,735 shares@ US$6.534.5% of flowCommon StockSEC:0001662579-24-000018:0
2,250 sharesCommon StockSEC:0001662579-23-000085:0
20,000 shares0Common StockSEC:0001662579-23-000038:0
3,750 sharesCommon StockSEC:0001662579-23-000019:0
1,102 shares@ US$7.015.6% of flowCommon StockSEC:0001209191-22-036718:0
3,750 sharesCommon StockSEC:0001209191-22-032515:0
12,500 shares@ US$4.9840.7% of flowCommon StockSEC:0001209191-21-055881:0
12,500 shares@ US$4.9840.5% of flowCommon StockSEC:0001209191-21-049120:0
11 of 11 declarations
About Siegel Jolie
Siegel Jolie is Director Juridique and Chief Legal Officer at C4 Therapeutics, Inc. He has 11 filings in total, and, within the sampled recent filings, the period runs from 2021-08-02 to 2025-02-18, with a modal transaction nature of option exercise. The buy and sell amounts indicated for this sample are 0 and 0.
